CAPTRUST Financial Advisors’s Ocular Therapeutix OCUL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	+12,637	New	+$115K	﹤0.01%	2999
2022 Q4	–	Sell	-11,500	Closed	-$48K	–	2147
2022 Q3	$48K	Buy	11,500 +1,000	+10%	+$5.04K	﹤0.01%	1987
2022 Q2	$42K	Buy	10,500 +10,000	+2,000%	+$37.8K	﹤0.01%	2885
2022 Q1	$2K	Hold	500	–	–	﹤0.01%	4516
2021 Q4	$3K	Hold	500	–	–	﹤0.01%	4293
2021 Q3	$5K	Hold	500	–	–	﹤0.01%	3949
2021 Q2	$7K	Hold	500	–	–	﹤0.01%	3714
2021 Q1	$8K	Hold	500	–	–	﹤0.01%	3548
2020 Q4	$10K	Hold	500	–	–	﹤0.01%	2573
2020 Q3	$4K	Hold	500	–	–	﹤0.01%	2598
2020 Q2	$4K	Buy	+500	New	+$3.31K	﹤0.01%	2454

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAPTRUST Financial Advisors's OCUL Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 12,637 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2999 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in OCUL as recently as Q3 2022.

CAPTRUST Financial Advisors first reported a position in OCUL in Q2 2020 and has held it in 11 quarters since. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

CAPTRUST Financial Advisors held 12,637 shares of Ocular Therapeutix worth $124K as of Q2 2026.
Ocular Therapeutix was a new CAPTRUST Financial Advisors position in Q2 2026.
Ocular Therapeutix made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2999 holding.
CAPTRUST Financial Advisors first reported a position in Ocular Therapeutix in Q2 2020 and has held it in 11 quarters since.
263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.